Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
Open accessAbstract
Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by nonhomologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for all four genes examined, up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like effector nucleases, and to nonmammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inhibiting the NHEJ pathway with gene silencing or chemical inhibitors can partially increase the efficiency of HDR pathway, but the gene repair efficacy still needs to be further improved for disease therapy.
“Although inhibiting the NHEJ pathway with gene silencing or chemical inhibitors can partially increase the efficiency of HDR pathway, the gene repair efficacy still needs to be further improved for disease therapy [82, 85].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390 · see citing works
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · see citing works
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495 · see citing works
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153 · see citing works
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856 · see citing works
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429 · see citing works
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851 · see citing works
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596 · see citing works
Double-strand break repair: 53BP1 comes into focus
Panier, S., & Boulton, S. J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3719 · Cited by 1,090 · see citing works
Kamentsky, L. D., Jones, T. R., Fraser, A. N., Bray, M., Logan, D. J., Madden, K. L., Ljosa, V., Rueden, C., Eliceiri, K. W., & Carpenter, A. E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr095 · Cited by 1,002 · see citing works
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Yin, H., Xue, W., Chen, S., Bogorad, R. L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P. A., Jacks, T., & Anderson, D. G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2884 · Cited by 951 · see citing works
Kaer, L. V., Ashton‐Rickardt, P. G., Ploegh, H. L., & Tonegawa, S. (1992) · Cell · doi:10.1016/s0092-8674(05)80068-6 · Cited by 725 · see citing works
Self-citationCorrection of a genetic disease in mouse via use of CRISPR-Cas9
Wu, Y., Liang, D., Wang, Y., Bai, M., Tang, W., Bao, S., Yan, Z., Li, D., & Li, J. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.10.016 · Cited by 614 · see citing works
Late embryonic lethality and impaired V (D)J recombination in mice lacking DNA ligase IV
Frank, K. M., Sekiguchi, J., Seidl, K. J., Swat, W., Rathbun, G. A., Cheng, H.-L., Davidson, L., Kangaloo, L., & Alt, F. W. (1998) · Nature · doi:10.1038/24172 · Cited by 594 · see citing works
Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cellsPreprint
Pierce, A. J., Hu, P., Han, M., Ellis, N. A., & Jasin, M. (2001) · Genes & Development · doi:10.1101/gad.946401 · Cited by 514 · see citing works
OS-9 and GRP94 deliver mutant α1-antitrypsin to the Hrd1–SEL1L ubiquitin ligase complex for ERAD
Christianson, J. C., Shaler, T. A., Tyler, R. E., & Kopito, R. R. (2008) · Nature Cell Biology · doi:10.1038/ncb1689 · Cited by 509 · see citing works
Srivastava, M., Nambiar, M., Sharma, S., Karki, S. S., Goldsmith, G., Hegde, M. B., Kumar, S., Pandey, M., Singh, R. K., Ray, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.054 · Cited by 374 · see citing works
Simsek, D., & Jasin, M. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1773 · Cited by 321 · see citing works
A Mouse Geneticist’s Practical Guide to CRISPR Applications
Singh, P., Schimenti, J. C., & Bolcun‐Filas, E. (2014) · Genetics · doi:10.1534/genetics.114.169771 · Cited by 303 · see citing works
Lighter: fast and memory-efficient sequencing error correction without counting
Song, L., Florea, L. D., & Langmead, B. (2014) · Genome Biology · doi:10.1186/s13059-014-0509-9 · Cited by 260 · see citing works
Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes
Shi, J., Kundrat, L., Pishesha, N., Bilate, A. M. B., Theile, C. S., Maruyama, T., Dougan, S. K., Ploegh, H. L., & Lodish, H. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409861111 · Cited by 212 · see citing works
Self-citationBoboilă, C., Yan, C. T., Wesemann, D. R., Janković, M., Wang, J. H., Manis, J. P., Nussenzweig, A., Nussenzweig, M. C., & Alt, F. W. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092449 · Cited by 198 · see citing works
Rinkevich, Y., Mori, T., Sahoo, D., Xu, P., Bermingham, J. R., & Weissman, I. L. (2012) · Nature Cell Biology · doi:10.1038/ncb2610 · Cited by 187 · see citing works
Alternative end-joining pathway(s): Bricolage at DNA breaks
Frit, P., Barboule, N., Yuan, Y., Gómez, D., & Calsou, P. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.02.007 · Cited by 166 · see citing works
Site‐Specific Protein Labeling via Sortase‐Mediated Transpeptidation
Popp, M. W., Antos, J. M., & Ploegh, H. L. (2009) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps1503s56 · Cited by 155 · see citing works
Self-citationAdachi, N., Ishino, T., Ishii, Y., Takeda, S., & Koyama, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201271098 · Cited by 155 · see citing works
Sphingomyelin Synthase 2 Deficiency Attenuates NFκB Activation
Hailemariam, T. K., Huan, C., Liu, J., Li, Z., Roman, C. A. J., Kalbfeisch, M., Bui, H. H., Peake, D. A., Kuo, M., Cao, G., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168682 · Cited by 153 · see citing works
Donor DNA Utilization During Gene Targeting with Zinc-Finger Nucleases
Beumer, K. J., Trautman, J. K., Mukherjee, K., & Carroll, D. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.005439 · Cited by 127 · see citing works
Lee, C. C., Freinkman, E., Sabatini, D. M., & Ploegh, H. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571257 · Cited by 79 · see citing works
Self-citationGenetic Interactions between BLM and DNA Ligase IV in Human Cells
So, S., Adachi, N., Lieber, M. R., & Koyama, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409827200 · Cited by 63 · see citing works
Sanyal, S., Ashour, J., Maruyama, T., Altenburg, A. F., Cragnolini, J. J., Bilate, A. M. B., Avalos, A. M., Kundrat, L., García‐Sastre, A., & Ploegh, H. L. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.10.011 · Cited by 55 · see citing works
Self-citationHovenden, M., Hubbard, M., AuCoin, D. P., Thorkildson, P., Reed, D. E., Welch, W. H., Lyons, C. R., Lovchik, J. A., & Kozel, T. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003306 · Cited by 36 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Search-and-replace genome editing without double-strand breaks or donor DNA
Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1711-4 · Cited by 4,767 · see citing works
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237 · see citing works
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,771 · see citing works
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Zhang, X.-H., Tee, L. Y., Wang, X.-G., Huang, Q.-S., & Yang, S.-H. (2015) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2015.37 · Cited by 1,273 · see citing works
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
Haapaniemi, E., Botla, S., Persson, J., Schmierer, B., & Taipale, J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0049-z · Cited by 1,264 · see citing works
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185 · see citing works
CRISPR/Cas9 in Genome Editing and Beyond
Wang, H., Russa, M. F. L., & Qi, L. S. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014607 · Cited by 1,165 · see citing works
Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L., & Corn, J. E. (2016) · Nature Biotechnology · doi:10.1038/nbt.3481 · Cited by 1,098 · see citing works
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2016) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,011 · see citing works
Applications of CRISPR technologies in research and beyond
Barrangou, R., & Doudna, J. A. (2016) · Nature Biotechnology · doi:10.1038/nbt.3659 · Cited by 1,005 · see citing works
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
Wright, A. V., Nuñez, J. K., & Doudna, J. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.035 · Cited by 1,001 · see citing works
Correction of a pathogenic gene mutation in human embryos
Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., et al. (2017) · Nature · doi:10.1038/nature23305 · Cited by 969 · see citing works
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951 · see citing works
Ahmar, S., Gill, R. A., Jung, K., Faheem, A., Qasim, M. U., Mubeen, M., & Zhou, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072590 · Cited by 612 · see citing works
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
Uddin, F. Z., Rudin, C. M., & Sen, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01387 · Cited by 605 · see citing works
Delivery technologies for genome editing
Yin, H., Kauffman, K. J., & Anderson, D. G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.280 · Cited by 597 · see citing works
Quadros, R. M., Miura, H., Harms, D. W., Akatsuka, H., Sato, T., Aida, T., Redder, R. J., Richardson, G. P., Inagaki, Y., Sakai, D., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1220-4 · Cited by 502 · see citing works
Induced Pluripotent Stem Cells Meet Genome Editing
Hockemeyer, D., & Jaenisch, R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.013 · Cited by 499 · see citing works
“Approaches to shift the balance away from NHEJ and towards homology-mediated repair included NHEJ inhibition with small molecules or by controlling the timing of CRISPR/Cas9 delivery with respect to the cell cycle stage (Chu et al., 2015; Maruyama et al., 2015; Robert et al., 2015; Yu et al., 2015).”
BackgroundDeWitt, M. A., Magis, W., Bray, N. L., Wang, T., Berman, J. R., Urbinati, F., Heo, S.-J., Mitros, T., Muñoz, D. P., Boffelli, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9336 · Cited by 477 · see citing works
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Cullot, G., Boutin, J., Toutain, J., Prat, F., Pennamen, P., Rooryck, C., Teichmann, M., Rousseau, E., Lamrissi-Garcia, I., Guyonnet-Duperat, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09006-2 · Cited by 474 · see citing works
Zhang, J., Li, X., Li, G., Chen, W., Arakaki, C., Botimer, G. D., Baylink, D. J., Zhang, L., Wen, W., Fu, Y.-W., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1164-8 · Cited by 473 · see citing works
DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks
van Overbeek, M., Capurso, D., Carter, M. M., Thompson, M. S., Frias, E., Russ, C., Reece-Hoyes, J. S., Nye, C., Gradia, S., Vidal, B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.037 · Cited by 454 · see citing works
Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.049 · Cited by 450 · see citing works
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Xue, C., & Greene, E. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.02.008 · Cited by 431 · see citing works
RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency
Song, J. W., Yang, D., Xu, J., Zhu, T., Chen, Y. E., & Zhang, J. (2016) · Nature Communications · doi:10.1038/ncomms10548 · Cited by 418 · see citing works
Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415 · see citing works
Advances in genome editing through control of DNA repair pathways
Yeh, C. D., Richardson, C. D., & Corn, J. E. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0425-z · Cited by 405 · see citing works
The emerging and uncultivated potential of CRISPR technology in plant science
Zhang, Y., Malzahn, A. A., Sretenovic, S., & Qi, Y. (2019) · Nature Plants · doi:10.1038/s41477-019-0461-5 · Cited by 404 · see citing works
Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.007 · Cited by 398 · see citing works
Bengtsson, N. E., Hall, J. K., Odom, G. L., Phelps, M. P., Andrus, C. R., Hawkins, R. D., Hauschka, S. D., Chamberlain, J. R., & Chamberlain, J. S. (2017) · Nature Communications · doi:10.1038/ncomms14454 · Cited by 387 · see citing works
DNA repair targeted therapy: The past or future of cancer treatment?
Gavande, N. S., VanderVere-Carozza, P. S., Hinshaw, H. D., Jalal, S. I., Sears, C. R., Pawelczak, K. S., & Turchi, J. J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.003 · Cited by 387 · see citing works
Garst, A. D., Bassalo, M. C., Pines, G., Lynch, S. A., Halweg‐Edwards, A. L., Liu, R., Liang, L., Wang, Z., Zeitoun, R. I., Alexander, W. G., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3718 · Cited by 356 · see citing works
Methodologies for Improving HDR Efficiency
Liu, M.-J., Rehman, S., Tang, X., Gu, K., Fan, Q., Chen, D., & Ma, W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00691 · Cited by 350 · see citing works
Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells
Koehler, K. R., Nie, J., Longworth-Mills, E., Liu, X.-P., Lee, J., Holt, J. R., & Hashino, E. (2017) · Nature Biotechnology · doi:10.1038/nbt.3840 · Cited by 341 · see citing works
He, X., Tan, C., Wang, F., Wang, Y., Zhou, R., Cui, D., You, W., Zhao, H., Ren, J., & Feng, B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw064 · Cited by 338 · see citing works
Homology-mediated end joining-based targeted integration using CRISPR/Cas9
Yao, X., Wang, X., Hu, X., Liu, Z., Liu, J., Zhou, H., Shen, X., Yu, W., Huang, Z., Ying, W., et al. (2017) · Cell Research · doi:10.1038/cr.2017.76 · Cited by 329 · see citing works
Origins of Programmable Nucleases for Genome Engineering
Chandrasegaran, S., & Carroll, D. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.10.014 · Cited by 327 · see citing works
Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes
Chu, V. T., Weber, T., Graf, R., Sommermann, T. G., Petsch, K., Sack, U., Volchkov, P., Rajewsky, K., & Kühn, R. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0234-4 · Cited by 312 · see citing works
Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity
Tycko, J., Myer, V. E., & Hsu, P. D. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.07.004 · Cited by 304 · see citing works
CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome
Shin, H. Y., Wang, C., Lee, H., Yoo, K. H., Zeng, X., Kuhns, T. M., Yang, C. M., Mohr, T., Liu, C., & Hennighausen, L. G. (2017) · Nature Communications · doi:10.1038/ncomms15464 · Cited by 303 · see citing works
Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
Gutschner, T., Hämmerle, M., Genovese, G., Draetta, G. F., & Chin, L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.019 · Cited by 296 · see citing works
Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors
Miura, H., Quadros, R. M., Gurumurthy, C. B., & Ohtsuka, M. (2017) · Nature Protocols · doi:10.1038/nprot.2017.153 · Cited by 295 · see citing works
CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases
Sharma, G., Sharma, A. R., Bhattacharya, M., Lee, S., & Chakraborty, C. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.028 · Cited by 295 · see citing works
Pinder, J. B., Salsman, J., & Dellaire, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv993 · Cited by 276 · see citing works
Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9
Du, H., Zeng, X., Zhao, M., Cui, X., Wang, Q., Yang, H., Cheng, H., & Yu, D. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.11.005 · Cited by 267 · see citing works
Monitoring T cell–dendritic cell interactions in vivo by intercellular enzymatic labelling
Pasqual, G., Chudnovskiy, A., Tas, J. M. J., Agudelo, M., Schweitzer, L. D., Cui, A., Hacohen, N., & Victora, G. D. (2018) · Nature · doi:10.1038/nature25442 · Cited by 266 · see citing works
Canny, M. D., Moatti, N., Wan, L. C. K., Fradet‐Turcotte, A., Krasner, D. S., Mateos‐Gómez, P. A., Zimmermann, M., Orthwein, A., Juang, Y.-C. A., Zhang, W., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.4021 · Cited by 265 · see citing works
Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization
Roberts, B., Haupt, A., Tucker, A., Grancharova, T., Arakaki, J., Fuqua, M. A., Nelson, A., Hookway, C., Ludmann, S. A., Mueller, I. A., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-03-0209 · Cited by 262 · see citing works
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
Taha, E. A., Lee, J., & Hotta, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.013 · Cited by 259 · see citing works
Yu, Q., Wang, B., Li, N., Tang, Y., Yang, S., Yang, T., Xu, J., Guo, C., Yan, P., Wang, Q., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12262-1 · Cited by 259 · see citing works
Yang, H., Ren, S., Yu, S., Pan, H., Li, T., Ge, S., Zhang, J., & Xia, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186461 · Cited by 258 · see citing works
Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
Robert, F., Barbeau, M., Ethier, S. D., Dostie, J., & Pelletier, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0215-6 · Cited by 253 · see citing works
Target-Specific Precision of CRISPR-Mediated Genome Editing
Chakrabarti, A. M., Henser‐Brownhill, T., Monserrat, J., Poetsch, A. R., Luscombe, N. M., & Scaffidi, P. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.11.031 · Cited by 250 · see citing works
Potential pitfalls of CRISPR /Cas9‐mediated genome editing
Peng, R., Lin, G., & Li, J. (2015) · FEBS Journal · doi:10.1111/febs.13586 · Cited by 248 · see citing works
Refining strategies to translate genome editing to the clinic
Cornu, T. I., Mussolino, C., & Cathomen, T. (2017) · Nature Medicine · doi:10.1038/nm.4313 · Cited by 247 · see citing works
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned
Morgan, R. A., Gray, D., Lomova, A., & Kohn, D. B. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.010 · Cited by 243 · see citing works
Liang, X., Potter, J., Kumar, S., Ravinder, N., & Chesnut, J. D. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.11.011 · Cited by 239 · see citing works
Single Cas9 nickase induced generation of NRAMP1 knockin cattle with reduced off-target effects
Gao, Y., Wu, H., Wang, Y., Liu, X., Chen, L., Li, Q., Cui, C., Liu, X., Zhang, J., & Zhang, Y. (2017) · Genome biology · doi:10.1186/s13059-016-1144-4 · Cited by 233 · see citing works
Use of designer nucleases for targeted gene and genome editing in plants
Weeks, D. P., Spalding, M. H., & Yang, B. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12448 · Cited by 229 · see citing works
Repair of DNA Double-Strand Breaks by the Nonhomologous End Joining Pathway
Stinson, B. M., & Loparo, J. J. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-080320-110356 · Cited by 223 · see citing works
Kon, S., Ishibashi, K., Katoh, H., Kitamoto, S., Shirai, T., Tanaka, S., Kajita, M., Ishikawa, S., Yamauchi, H., Yako, Y., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3509 · Cited by 223 · see citing works
Self-citationCRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Hoban, M. D., Lumaquin, D., Kuo, C. Y., Romero, Z., Long, J., Ho, M., Young, C. S., Mojadidi, M., Fitz-Gibbon, S., Cooper, A. R., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.148 · Cited by 220 · see citing works
Mikuni, T., Nishiyama, J., Sun, Y., Kamasawa, N., & Yasuda, R. (2016) · Cell · doi:10.1016/j.cell.2016.04.044 · Cited by 214 · see citing works
CRISPR-based genome editing through the lens of DNA repair
Nambiar, T. S., Baudrier, L., Billon, P., & Ciccia, A. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.026 · Cited by 214 · see citing works
Recent advances in the CRISPR genome editing tool set
Moon, S. B., Kim, D. Y., Ko, J., & Kim, Y.-S. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0339-7 · Cited by 208 · see citing works
Komuczki, J., Tuzlak, S., Friebel, E., Hartwig, T., Spath, S., Rosenstiel, P., Waisman, A., Opitz, L., Oukka, M., Schreiner, B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.006 · Cited by 201 · see citing works
György, B., Lööv, C., Zaborowski, M. P., Takeda, S., Kleinstiver, B. P., Commins, C., Kastanenka, K. V., Mu, D., Volak, A., Giedraitis, V., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.03.007 · Cited by 200 · see citing works
Yang, D., Scavuzzo, M. A., Chmielowiec, J., Sharp, R., Bajić, A., & Borowiak, M. (2016) · Scientific Reports · doi:10.1038/srep21264 · Cited by 198 · see citing works
CRISPR Cpf1 proteins: structure, function and implications for genome editing
Safari, F., Zare, K., Negahdaripour, M., Barekati‐Mowahed, M., & Ghasemi, Y. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0298-7 · Cited by 196 · see citing works
CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Hendriks, D. F. G., Clevers, H. C., & Artegiani, B. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.10.014 · Cited by 196 · see citing works
Early and late stage gene therapy interventions for inherited retinal degenerations
Botto, C., Rucli, M., Tekinsoy, M. D., Pulman, J., Sahel, J.-A., & Dalkara, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100975 · Cited by 190 · see citing works
Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System
Wang, K., Ouyang, H., Xie, Z., Yao, C., Guo, N., Li, M., Jiao, H., & Pang, D. (2015) · Scientific Reports · doi:10.1038/srep16623 · Cited by 190 · see citing works
Development of CRISPR-Cas systems for genome editing and beyond
Zhang, F. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583519000052 · Cited by 185 · see citing works
Rational designs of in vivo CRISPR-Cas delivery systems
Xu, C., Chen, G., Luo, Y., Zhang, Y., Zhao, G., Lu, Z.-D., Czarna, A., Gu, Z., & Wang, J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.005 · Cited by 185 · see citing works
Precision genome editing in the CRISPR era
Salsman, J., & Dellaire, G. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0137 · Cited by 183 · see citing works
Mapping the genetic landscape of DNA double-strand break repair
Hussmann, J. A., Jia, L., Ravisankar, P., Yan, J., Cirincione, A., Xu, A., Simpson, D., Yang, D., Bothmer, A., Cotta‐Ramusino, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.002 · Cited by 182 · see citing works
Recent Progress in CRISPR/Cas9 Technology
Mei, Y., Wang, Y., Chen, H., Sun, Z. S., & Ju, X. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.01.001 · Cited by 181 · see citing works
CRISPR-Cas9-mediated homology-directed repair for precise gene editing
Liao, H., Wu, J., VanDusen, N. J., Li, Y., & Zheng, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102344 · Cited by 181 · see citing works
Bandyopadhyay, A., Kancharla, N., Javalkote, V. S., Dasgupta, S., & Brutnell, T. P. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.584151 · Cited by 179 · see citing works
Fu, Y.-W., Dai, X., Wang, W., Yang, Z.-X., Zhao, J.-J., Zhang, J., Wen, W., Zhang, F., Oberg, K. C., Zhang, L., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1251 · Cited by 176 · see citing works
Critical roles of long noncoding RNAs in Drosophila spermatogenesisPreprint
Wen, K., Yang, L., Xiong, T., Di, C., Ma, D., Wu, M., Xue, Z., Zhang, X., Li, L., Zhang, W., et al. (2016) · Genome Research · doi:10.1101/gr.199547.115 · Cited by 176 · see citing works
Riesenberg, S., & Maricic, T. (2018) · Nature Communications · doi:10.1038/s41467-018-04609-7 · Cited by 174 · see citing works
Marker-free coselection for CRISPR-driven genome editing in human cells
Agudelo, D., Duringer, A., Bozoyan, L., Huard, C., Carter, S., Loehr, J., Synodinou, D., Drouin, M., Salsman, J., Dellaire, G., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4265 · Cited by 174 · see citing works
Bispecific antibodies targeting mutant <i>RAS</i> neoantigens
Douglass, J., Hsiue, E. H.-C., Mog, B. J., Hwang, M. S., DiNapoli, S. R., Pearlman, A. H., Miller, M. S., Wright, K. M., Azurmendi, P. A., Wang, Q., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd5515 · Cited by 171 · see citing works
Carlson-Stevermer, J., Abdeen, A. A., Kohlenberg, L., Goedland, M., Molugu, K., Lou, M., & Saha, K. (2017) · Nature Communications · doi:10.1038/s41467-017-01875-9 · Cited by 170 · see citing works
Savić, N., Ringnalda, F. C. A. S., Lindsay, H. A., Berk, C., Bargsten, K., Li, Y., Neri, D., Robinson, M. D., Ciaudo, C., Hall, J., et al. (2018) · eLife · doi:10.7554/elife.33761 · Cited by 169 · see citing works
CRISPR-Cas9D10A nickase-based genotypic and phenotypic screening to enhance genome editing
Chiang, T.-W. W., le Sage, C., Larrieu, D., Demir, M., & Jackson, S. P. (2016) · Scientific Reports · doi:10.1038/srep24356 · Cited by 165 · see citing works
Exploring the potential of genome editing CRISPR-Cas9 technology
Singh, V., Braddick, D., & Dhar, P. K. (2016) · Gene · doi:10.1016/j.gene.2016.11.008 · Cited by 164 · see citing works
Jayavaradhan, R., Pillis, D. M., Goodman, M., Zhang, F., Zhang, Y., Andreassen, P. R., & Malik, P. (2019) · Nature Communications · doi:10.1038/s41467-019-10735-7 · Cited by 164 · see citing works
Jenko, J., Gorjanc, G., Cleveland, M. A., Varshney, R. K., Whitelaw, B., Woolliams, J. A., & Hickey, J. M. (2015) · Genetics Selection Evolution · doi:10.1186/s12711-015-0135-3 · Cited by 163 · see citing works
Gene targeting, genome editing: from Dolly to editors
Tan, W. S., Proudfoot, C., Lillico, S. G., & Whitelaw, B. (2016) · Transgenic Research · doi:10.1007/s11248-016-9932-x · Cited by 163 · see citing works
Zebrafish Genome Engineering Using the CRISPR–Cas9 System
Li, M., Zhao, L., Page-McCaw, P., & Chen, W. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.10.005 · Cited by 162 · see citing works
Lau, C.-H., & Suh, Y. (2017) · F1000Research · doi:10.12688/f1000research.11243.1 · Cited by 161 · see citing works
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
Yang, Y., Xu, J., Ge, S., & Lai, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.649896 · Cited by 160 · see citing works
Pishesha, N., Bilate, A. M. B., Wibowo, M. C., Huang, N.-J., Li, Z., Deshycka, R., Bousbaine, D., Li, H., Patterson, H. C., Dougan, S. K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701746114 · Cited by 156 · see citing works
Self-citationGenome editing using CRISPR/Cas9-based knock-in approaches in zebrafish
Albadri, S., Bene, F. D., & Revenu, C. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.005 · Cited by 152 · see citing works
Generating mouse models for biomedical research: technological advances
Gurumurthy, C. B., & Lloyd, K. C. K. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.029462 · Cited by 152 · see citing works
Park, S. H., Lee, C. M., Dever, D. P., Davis, T., Camarena, J., Srifa, W., Zhang, Y., Paikari, A., Chang, A. K., Porteus, M. H., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz475 · Cited by 147 · see citing works
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Dai, W.-J., Zhu, L., Yan, Z., Xu, Y., Wang, Q., & Lu, X. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.58 · Cited by 144 · see citing works
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
Han, H. A., Pang, J. K. S., & Soh, B.-S. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01893-z · Cited by 143 · see citing works
- Authors
- Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Ploegh, Hidde L
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2015-03-23
- Volume
- 33
- Issue
- 5
- Pages
- 538-542
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4618510
- OpenAlex
- W2008147758
- Cited by
- 1,137
- References
- 32
- Citations by year
- 2026: 39 · 2025: 58 · 2024: 62 · 2023: 67 · 2022: 108 · 2021: 101 · 2020: 117 · 2019: 122 · 2018: 125 · 2017: 139 · 2016: 143 · 2015: 55
- FWCI
- 66.47
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-02-05)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI087879)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, genome editing efficiency, non-homologous end joining, homology-directed repair, DNA ligase IV, DNA double-strand break repair, zinc finger nucleases, TALEN
- MeSH terms
- DNA Ligase ATP, Animals, Cell Line, DNA Repair, Genetic Engineering, DNA Ligases, Pyrimidines, Schiff Bases, Zinc Fingers, Genome, Mice, DNA Breaks, Double-Stranded, Homologous Recombination, DNA End-Joining Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review